Evidence map›Paper›PMID 31882563›Full record

ArticleDiabetes2020

HB-EGF Signaling Is Required for Glucose-Induced Pancreatic β-Cell Proliferation in Rats.

Hasna Maachi, Grace Fergusson, Melanie Ethier, Gabriel N Brill, Liora S Katz, Lee B Honig, Mallikarjuna R Metukuri, Donald K Scott, Julien Ghislain, Vincent Poitout

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Journal of diabetes research · 2025
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Hasna MaachiMontreal Diabetes Research Center, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Grace FergussonMontreal Diabetes Research Center, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Melanie EthierMontreal Diabetes Research Center, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Gabriel N BrillDiabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Liora S KatzDiabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Lee B HonigDiabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Mallikarjuna R MetukuriDivision of Endocrinology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Donald K ScottDiabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY.ORCID 0000-0002-1414-9223
Julien GhislainMontreal Diabetes Research Center, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Vincent PoitoutMontreal Diabetes Research Center, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada vincent.poitout@umontreal.ca.ORCID 0000-0002-6555-5053
Centre Hospitalier de l’Université de Montréal · CAIcahn School of Medicine at Mount Sinai · USUniversity of Pittsburgh · US

Funding

Integrated Islet Distribution Program (U24) - 2021U24DK098085 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI Carmella Evans-Molina, Joyce Carol Niland · 2021 to 2026
$17.8M
Neutral lipid dysregulation of the pancreatic beta-cellR01DK058096 · NIDDK · UNIVERSITY OF MONTREAL HOSPITAL · PI POITOUT, VINCENT · 2001 to 2020
$3.9M
ChREBP Isoforms in Pancreatic Beta CellsR01DK108905 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SCOTT, DONALD K. · 2017 to 2020
$1.7M
CIHR MOP 77686NIDDK NIH HHS R01 DK058096NIDDK NIH HHS R01 DK108905NIDDK NIH HHS U24 DK098085
6 · The paper itself

Abstract

The molecular mechanisms of β-cell compensation to metabolic stress are poorly understood. We previously observed that nutrient-induced β-cell proliferation in rats is dependent on epidermal growth factor receptor (EGFR) signaling. The aim of this study was to determine the role of the EGFR ligand heparin-binding EGF-like growth factor (HB-EGF) in the β-cell proliferative response to glucose, a β-cell mitogen and key regulator of β-cell mass in response to increased insulin demand. We show that exposure of isolated rat and human islets to HB-EGF stimulates β-cell proliferation. In rat islets, inhibition of EGFR or HB-EGF blocks the proliferative response not only to HB-EGF but also to glucose. Furthermore, knockdown of HB-EGF in rat islets blocks β-cell proliferation in response to glucose ex vivo and in vivo in transplanted glucose-infused rats. Mechanistically, we demonstrate that HB-EGF mRNA levels are increased in β-cells in response to glucose in a carbohydrate-response element-binding protein (ChREBP)-dependent manner. In addition, chromatin immunoprecipitation studies identified ChREBP binding sites in proximity to the HB-EGF gene. Finally, inhibition of Src family kinases, known to be involved in HB-EGF processing, abrogated glucose-induced β-cell proliferation. Our findings identify a novel glucose/HB-EGF/EGFR axis implicated in β-cell compensation to increased metabolic demand.

Indexed as

AnimalsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCell ProliferationChromatin ImmunoprecipitationErbB ReceptorsGene Knockdown TechniquesGlucoseHeparin-binding EGF-like Growth FactorHumansInsulin-Secreting CellsIslets of LangerhansRatsRNA, MessengerSignal Transductionsrc-Family KinasesBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsEGFR protein, humanEgfr protein, ratErbB ReceptorsGlucoseHeparin-binding EGF-like Growth FactorMlxipl protein, ratRNA, Messengersrc-Family Kinases

Identifiers

PMID31882563
PMCPMC7034189
OpenAlexW2948077371

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.